Drug Name: | Prednisone (53-03-2) |
---|---|
PubChem ID: | 5865 |
SMILES: | C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C |
InchiKey: | XOFYZVNMUHMLCC-ZPOLXVRWSA-N |
Therapeutic Category: | Adrenal Cortex Hormones, Anti-Inflammatory Agents, Antineoplastic Agents, Glucocorticoids, Hormones |
Molecular Weight (dalton) | : | 358.434 |
LogP | : | 1.7658 |
Ring Count | : | 0 |
Hydrogen Bond Acceptor Count | : | 5 |
Hydrogen Bond Donor Count | : | 2 |
Total Polar Surface Area | : | 91.67 |
This panel provides information on interacting drugs and their ADRs along with references
Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
---|---|---|---|---|
Chlorambucil (305-03-3) | Generalised Tonic-Clonic Seizure | Additives | The seizures in this patient may have been due to the additive effects of both drugs | Chlorambucil/prednisone-induced seizures in a patient with non-Hodgkin's lymphoma |
This panel provides drug-protein interaction and their ADRs along with references
Toxicity | Interacting Protein | Mechanism | Reference |
---|---|---|---|
Depression | Beta-2 adrenergic receptor (P07550) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
This panel provides drug-food interactions and their ADRs along with references
Food | Toxicity | Reference |
---|
This panel provides information on metabolites and their ADRs along with references
Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
---|
This panel provides information on drug category